Connection
Kristen Kelly to Neurofibromatosis 1
This is a "connection" page, showing publications Kristen Kelly has written about Neurofibromatosis 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.154 |
|
|
|
-
Li Y, Blakeley JO, Ly I, Berman Y, Lau J, Wolkenstein P, Bergqvist C, Jia W, Milner TE, Katta N, Durkin AJ, Kennedy GT, Rowland R, Romo CG, Fleming J, Kelly KM. Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous Neurofibromas. J Invest Dermatol. 2023 08; 143(8):1397-1405.
Score: 0.744
-
Jia W, Katta N, Kennedy GT, Lee J, Nguyen E, Lai O, Jeong Y, Elsanadi R, Messele F, Johnson JE, Stemmer-Rachamimov AO, Nelson JS, Sierra R, Kelly KM, Durkin AJ, Milner TE. Optical and acoustic scattering in cutaneous neurofibromas: Implications for early detection. J Invest Dermatol. 2026 Sep; 146(9):2530-2540.e7.
Score: 0.224
-
Ly I, Romo CG, Gottesman S, Kelly KM, Kornacki D, York Z, Lee SY, Rhodes SD, Staedtke V, Steensma MR, Blakeley JO, Wolkenstein P. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas. J Invest Dermatol. 2023 08; 143(8):1388-1396.
Score: 0.186
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|